Cargando…
P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429229/ http://dx.doi.org/10.1097/01.HS9.0000847384.23751.21 |
| _version_ | 1784779374221852672 |
|---|---|
| author | Strati, P. Coleman, M. Stevens, D. Ma, S. Patti, C. Levy, M. Lossos, I. S. Ramakrishnan Geethakumari, P. Lam, S. Calvo, R. Higgins, K. Budde, L. |
| author_facet | Strati, P. Coleman, M. Stevens, D. Ma, S. Patti, C. Levy, M. Lossos, I. S. Ramakrishnan Geethakumari, P. Lam, S. Calvo, R. Higgins, K. Budde, L. |
| author_sort | Strati, P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429229 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94292292022-08-31 P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL Strati, P. Coleman, M. Stevens, D. Ma, S. Patti, C. Levy, M. Lossos, I. S. Ramakrishnan Geethakumari, P. Lam, S. Calvo, R. Higgins, K. Budde, L. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429229/ http://dx.doi.org/10.1097/01.HS9.0000847384.23751.21 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Strati, P. Coleman, M. Stevens, D. Ma, S. Patti, C. Levy, M. Lossos, I. S. Ramakrishnan Geethakumari, P. Lam, S. Calvo, R. Higgins, K. Budde, L. P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL |
| title | P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL |
| title_full | P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL |
| title_fullStr | P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL |
| title_full_unstemmed | P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL |
| title_short | P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL |
| title_sort | p1129: acalabrutinib in patients with relapsed/refractory (r/r) marginal zone lymphoma (mzl): results of a phase 2, multicenter, open-label trial |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429229/ http://dx.doi.org/10.1097/01.HS9.0000847384.23751.21 |
| work_keys_str_mv | AT stratip p1129acalabrutinibinpatientswithrelapsedrefractoryrrmarginalzonelymphomamzlresultsofaphase2multicenteropenlabeltrial AT colemanm p1129acalabrutinibinpatientswithrelapsedrefractoryrrmarginalzonelymphomamzlresultsofaphase2multicenteropenlabeltrial AT stevensd p1129acalabrutinibinpatientswithrelapsedrefractoryrrmarginalzonelymphomamzlresultsofaphase2multicenteropenlabeltrial AT mas p1129acalabrutinibinpatientswithrelapsedrefractoryrrmarginalzonelymphomamzlresultsofaphase2multicenteropenlabeltrial AT pattic p1129acalabrutinibinpatientswithrelapsedrefractoryrrmarginalzonelymphomamzlresultsofaphase2multicenteropenlabeltrial AT levym p1129acalabrutinibinpatientswithrelapsedrefractoryrrmarginalzonelymphomamzlresultsofaphase2multicenteropenlabeltrial AT lossosis p1129acalabrutinibinpatientswithrelapsedrefractoryrrmarginalzonelymphomamzlresultsofaphase2multicenteropenlabeltrial AT ramakrishnangeethakumarip p1129acalabrutinibinpatientswithrelapsedrefractoryrrmarginalzonelymphomamzlresultsofaphase2multicenteropenlabeltrial AT lams p1129acalabrutinibinpatientswithrelapsedrefractoryrrmarginalzonelymphomamzlresultsofaphase2multicenteropenlabeltrial AT calvor p1129acalabrutinibinpatientswithrelapsedrefractoryrrmarginalzonelymphomamzlresultsofaphase2multicenteropenlabeltrial AT higginsk p1129acalabrutinibinpatientswithrelapsedrefractoryrrmarginalzonelymphomamzlresultsofaphase2multicenteropenlabeltrial AT buddel p1129acalabrutinibinpatientswithrelapsedrefractoryrrmarginalzonelymphomamzlresultsofaphase2multicenteropenlabeltrial |